Skip to main content
رجوع
HYPMY logo

Hypera S.A.

جودة البيانات: 100%
HYPMY
OTC Healthcare Drug Manufacturers - Specialty & Generic
KWD 4.49
▼ KWD 0.02 (-0.44%)
القيمة السوقية: 3.14B
نطاق اليوم
KWD 4.40 KWD 4.57
نطاق 52 أسبوعًا
KWD 3.17 KWD 5.50
حجم التداول
10,900
متوسط 50 يوم / 200 يوم
KWD 4.46 / KWD 4.48
الإغلاق السابق
KWD 4.51

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 2.6 0.2
P/B 0.3 3.0
ROE % 9.7 3.6
Net Margin % 15.5 3.8
Rev Growth 5Y % 6.7 9.9
D/E 0.8 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2027 KWD 0.00
KWD 0.00 – KWD 0.00
10.06B 0
FY2026 KWD 0.00
KWD 0.00 – KWD 0.00
9.20B 0

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-12 N/A KWD 0.13
2025-11-12 N/A KWD 0.13
2025-08-06 N/A KWD 0.12
2025-04-23 N/A -KWD 0.04
2024-12-31 N/A KWD 0.02
2024-11-13 N/A KWD 0.11
2024-07-25 N/A KWD 0.15
2024-04-26 N/A KWD 0.12

Dividend History

7 yr streak

Yield

0.04%

Payout Ratio

0.53%

Growth (3Y)

8.96%

Growth (5Y)

0.40%

Ex-Date Payment Date Amount Yield
Mar 02, 2026 Mar 09, 2026 KWD 0.05 4.75%
Dec 30, 2025 KWD 0.04 5.32%
Oct 06, 2025 KWD 0.04 4.68%
Jun 30, 2025 KWD 0.05 4.24%
Apr 04, 2025 KWD 0.05 5.79%
Jan 10, 2025 KWD 0.02 7.39%
Jan 06, 2025 KWD 0.03 6.26%
Oct 04, 2024 KWD 0.04 4.40%
Aug 01, 2024 KWD 0.02 4.80%
Jul 01, 2024 KWD 0.02 4.24%
May 31, 2024 KWD 0.02 3.86%
May 02, 2024 KWD 0.02 3.09%
Mar 22, 2024 KWD 0.02 3.07%
Mar 01, 2024 KWD 0.02 2.69%
Feb 08, 2024 KWD 0.02 2.65%
Dec 28, 2023 Jan 07, 2024 KWD 0.05 1.95%
Oct 05, 2023 Jan 07, 2024 KWD 0.05 2.38%
Jul 06, 2023 Jan 07, 2024 KWD 0.05 1.17%
Dec 29, 2022 Jan 12, 2023 KWD 0.06 2.00%
Jul 01, 2022 Jan 12, 2023 KWD 0.06 3.15%

النقاط الرئيسية

Revenue grew 6.71% annually over 5 years — modest growth
Earnings declined -10.86% over the past year
Net margin of 15.53% shows strong profitability
Generating 1.78B in free cash flow
P/E of 2.63 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.26%

النمو

Revenue Growth (5Y)
6.71%
Revenue (1Y)3.45%
Earnings (1Y)-10.86%
FCF Growth (3Y)5.88%

الجودة

Return on Equity
9.71%
ROIC5.96%
Net Margin15.53%
Op. Margin22.57%

الأمان

Debt / Equity
0.75
Current Ratio1.47
Interest Coverage1.67

التقييم

P/E Ratio
2.63
Forward P/EN/A
P/B Ratio0.25
EV/EBITDA6.23
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 3.45% Revenue Growth (3Y) -1.37%
Earnings Growth (1Y) -10.86% Earnings Growth (3Y) -14.83%
Revenue Growth (5Y) 6.71% Earnings Growth (5Y) -2.64%
Profitability
Revenue (TTM) 7.70B Net Income (TTM) 1.20B
ROE 9.71% ROA 4.75%
Gross Margin 59.04% Operating Margin 22.57%
Net Margin 15.53% Free Cash Flow (TTM) 1.78B
ROIC 5.96% FCF Growth (3Y) 5.88%
Safety
Debt / Equity 0.75 Current Ratio 1.47
Interest Coverage 1.67
Dividends
Dividend Yield 0.04% Payout Ratio 0.53%
Dividend Growth (3Y) 8.96% Dividend Growth (5Y) 0.40%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 2.63 Forward P/E N/A
P/B Ratio 0.25 P/S Ratio 0.41
PEG Ratio -1.11 Forward PEG N/A
EV/EBITDA 6.23 Fwd EV/EBITDA 3.49
Forward P/S 0.34 Fwd Earnings Yield N/A
FCF Yield 56.55%
Market Cap 3.14B Enterprise Value 10.83B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 7.70B 7.44B 7.91B 7.55B 5.94B
Net Income 1.20B 1.34B 1.65B 1.70B 1.33B
EPS (Diluted) 1.89 2.10 2.58 2.65 2.08
Gross Profit 4.55B 4.38B 5.00B 4.76B 3.80B
Operating Income 1.74B 1.80B 2.29B 2.64B 2.04B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 25.16B 24.56B 24.51B 23.76B 19.82B
Total Liabilities 12.63B 12.46B 12.99B 13.10B 9.98B
Shareholders' Equity 12.52B 12.10B 11.50B 10.65B 9.83B
Total Debt 9.34B 9.40B 9.96B 9.68B 7.41B
Cash & Equivalents 1.65B 1.74B 2.58B 2.86B 2.29B
Current Assets 6.05B 6.68B 8.08B 8.53B 6.49B
Current Liabilities 4.11B 3.94B 4.64B 5.23B 2.78B